-
1
-
2
Artificial 64-Residue HIV-1 Enhancer-Binding Peptide Is a Potent Inhibitor of Viral Replication in HIV-1-Infected Cells
Published 2011-01-01“…Moreover, HIV-1 replication is inhibited by this peptide in HIV-1-infected CEM-GFP cells as revealed by HIV-1 p24 ELISA and real-time RT-PCR of HIV-1 RNA. …”
Get full text
Article -
3
Impact of Tat Genetic Variation on HIV-1 Disease
Published 2012-01-01“…The human immunodeficiency virus type 1 (HIV-1) promoter or long-terminal repeat (LTR) regulates viral gene expression by interacting with multiple viral and host factors. …”
Get full text
Article -
4
Incompletely closed HIV-1CH040 envelope glycoproteins resist broadly neutralizing antibodies while mediating efficient HIV-1 entry
Published 2025-01-01“…Abstract HIV-1 envelope glycoproteins (Envs) mediate viral entry and are sole target of neutralizing antibodies. …”
Get full text
Article -
5
Model systems of human immunodef iciency virus (HIV-1) for in vitro eff icacy assessment of candidate vaccines and drugs against HIV-1
Published 2022-04-01Subjects: “…hiv-1…”
Get full text
Article -
6
-
7
Tuberculous Osteomyelitis of the Scapular Spine Revealing HIV-1 Infection
Published 2024-12-01Subjects: Get full text
Article -
8
Modeling the co-infection of HTLV-2 and HIV-1 in vivo
Published 2024-11-01Subjects: Get full text
Article -
9
Clinical Significance and Characterization of AZT-Resistant Strains of HIV-1
Published 1991-01-01“…A number of laboratories have now independently confirmed that zidovudine (AZT)-resistant strains of human immunodeficiency virus type 1 (HIV-1) may be isolated from patients undergoing prolonged therapy with this drug. …”
Get full text
Article -
10
Host RNA-Binding Proteins as Regulators of HIV-1 Replication
Published 2024-12-01Subjects: “…HIV-1…”
Get full text
Article -
11
Characterization of the Protective HIV-1 CTL Epitopes and the Corresponding HLA Class I Alleles: A Step towards Designing CTL Based HIV-1 Vaccine
Published 2014-01-01“…This study was designed for the characterization the HIV-1 optimal CTL epitopes and their corresponding HLA alleles. …”
Get full text
Article -
12
The Potential Use of the CRISPR-Cas System for HIV-1 Gene Therapy
Published 2019-01-01“…The HIV-1 virus (human immunodeficiency virus) affects 36.9 million people worldwide, with approximately 900000 deaths in 2017. …”
Get full text
Article -
13
Study of Body Composition and Metabolic Parameters in HIV-1 Male Patients
Published 2014-01-01Get full text
Article -
14
Global Stability of HIV-1 Infection Model with Two Time Delays
Published 2013-01-01Get full text
Article -
15
Dynamical Analysis of Approximate Solutions of HIV-1 Model with an Arbitrary Order
Published 2019-01-01“…This article studies the dynamical behavior of the analytical solutions of the system of fraction order model of HIV-1 infection. For this purpose, first, the proposed integer order model is converted into fractional order model. …”
Get full text
Article -
16
T Cell Activation and Regulation of HIV-1: Same Effectors with Distinct Outcomes
Published 1999-01-01“…The molecular mechanisms that regulate the function of the immune system and human immunodeficiency virus type-1 (HIV-1) gene expression are diverse and complicated. …”
Get full text
Article -
17
Is PPAR𝛾 a Prospective Player in HIV-1-Associated Bone Disease?
Published 2009-01-01“…Currently infection with the human immunodeficiency virus-1 (HIV-1) is in most instances a chronic disease that can be controlled by effective antiretroviral therapy (ART). …”
Get full text
Article -
18
Large-scale screening of HIV-1 T-cell epitopes restricted by 12 prevalent HLA-A allotypes in Northeast Asia and universal detection of HIV-1-specific CD8+ T cells
Published 2025-02-01Subjects: “…HIV-1…”
Get full text
Article -
19
Modeling Cancer in HIV-1 Infected Individuals: Equilibria, Cycles and Chaotic Behavior
Published 2006-01-01Subjects: Get full text
Article -
20
Impact of delay on HIV-1 dynamics of fighting a virus withanother virus
Published 2014-05-01Subjects: Get full text
Article